REGISTERED
on 09 Jan 2024
Last Applicant/ Owned by
301 - 980 George Street
Vancouver
CA
V6A0H9
Serial Number
90793184 filed on 24th Jun 2021
Registration Number
7270328 registered on 09th Jan 2024
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
INCISIVE GENETICS
Scientific and medical research Reagents, namely, lipid nanoparticles, for scientific and research use Pharmaceutical drug delivery system, namely, lipid nanoparticles, for medicinal use; Pharmaceutical preparations, namely, a lipid-enabled drug delivery system for genetic medicines
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific and medical research
First Use Date in General
30th May 2022
First Use Date in Commerce
30th May 2022
Class [005]
Pharmaceutical Products
Pharmaceutical drug delivery system, namely, lipid nanoparticles, for medicinal use; Pharmaceutical preparations, namely, a lipid-enabled drug delivery system for genetic medicines
First Use Date in General
30th May 2022
First Use Date in Commerce
30th May 2022
Class [001]
Chemical Products
Reagents, namely, lipid nanoparticles, for scientific and research use
First Use Date in General
30th May 2022
First Use Date in Commerce
30th May 2022
Mark Details
Serial Number
No 90793184
Mark Type
No Service Mark
Attorney Docket Number
No 2957415.100
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Jan 2024 | REGISTERED-PRINCIPAL REGISTER |
| 09th Jan 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 02th Dec 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 01st Dec 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 28th Nov 2023 | ASSIGNED TO LIE |
| 28th Nov 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 28th Nov 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 22nd Jun 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 22nd Mar 2023 | SU - NON-FINAL ACTION - WRITTEN |
| 22nd Mar 2023 | NON-FINAL ACTION E-MAILED |